title: Complement component C9 in Graves' disease.
abstract: C9, the terminal component of complement, is the key part of the membrane attack complex formed as a result of complement activation; it has also been reported to be an acute phase protein. Its potential role in Graves' disease has been studied by measuring plasma C9 concentrations using an automated two-site immunoradiometric assay employing monoclonal antibodies, whose binding to thyroid tissue has also been investigated. The plasma C9 concentration in patients with hyperthyroid Graves' disease (86.3 +/- 21.6 mg/l, mean +/- SD; n = 49) was significantly increased (P less than 0.001) compared with normal subjects (60.4 +/- 13.4 mg/l; n = 48). In contrast, the plasma concentration of C-reactive protein, a marker of the acute phase response, was not significantly different between the two groups. The plasma C9 concentration in patients with hyperthyroid Graves' disease decreased significantly (P less than 0.01) after treatment with antithyroid drugs (carbimazole or methimazole; n = 14), but not after radioactive iodine (131I) treatment (n = 18). Immunohistochemical staining demonstrated that monoclonal antibody to C9 bound to the basement membranes of thyroid follicular cells of Graves' thyroid tissue but not to normal thyroid tissue. Radiolabelled monoclonal antibody to C9 bound to membrane fragments prepared from thyroid glands from two patients with Graves' disease. We conclude that C9, and by implication the membrane attack complex, may be involved in the pathogenesis of Graves' disease.
authors.affiliation: Department of Medical Biochemistry, University Hospital of Wales, UK.
authors.forename: D A
authors.initials: DA
authors.lastname: Oleesky
authors.forename: S
authors.initials: S
authors.lastname: Ratanachaiyavong
authors.forename: M
authors.initials: M
authors.lastname: Ludgate
authors.forename: B P
authors.initials: BP
authors.lastname: Morgan
authors.forename: A K
authors.initials: AK
authors.lastname: Campbell
authors.forename: A M
authors.initials: AM
authors.lastname: McGregor
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal; D002097:C-Reactive Protein / Q000032:analysis; D003186:Complement C9 / Q000032:analysis*; D006111:Graves Disease / Q000276:immunology* / Q000628:therapy; D006801:Humans; D007124:Immunoenzyme Techniques; D008875:Middle Aged; D011863:Radioimmunoassay; D013961:Thyroid Gland / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D003186:Complement C9; D002097:C-Reactive Protein